|
|
Previous Article | Table of Contents | Next Article 
Identification of Human and Mouse Hematopoietic Stem Cell Populations
Expressing High Levels of mRNA Encoding Retrovirus Receptors
Donald Orlic,
Laurie J. Girard,
Stacie M. Anderson,
Louise C. Pyle,
Mervin C. Yoder,
Hal E. Broxmeyer, and
David M. Bodine
From the Hematopoiesis Section, Laboratory of Gene Transfer, National
Human Genome Research Institute (NHGRI), National Institutes of Health
(NIH), Bethesda, MD; the Department of Pediatrics, Riley Hospital for
Children; the Departments of Microbiology/Immunology and Medicine; and
the Walther Oncology Center, Indiana University School of Medicine,
Indianapolis, IN.
One obstacle to retrovirus-mediated gene therapy for human
hematopoietic disorders is the low efficiency of gene transfer into
pluripotent hematopoietic stem cells (HSC). We have previously shown a
direct correlation between retrovirus receptor mRNA levels in mouse HSC
and the efficiency with which they are transduced. In the present
study, we assayed retrovirus receptor mRNA levels in a variety of mouse
and human HSC populations to identify HSC which may be more competent
for retrovirus transduction. The highest levels of amphotropic
retrovirus receptor (amphoR) mRNA were found in cryopreserved human
cord blood HSC. The level of amphoR mRNA in Lin
CD34+ CD38 cells isolated from frozen cord
blood was 12-fold higher than the level in fresh cord blood
Lin CD34+ CD38 cells. In
mice, the level of amphoR mRNA in HSC from the bone marrow (BM) of mice
treated with stem cell factor and granulocyte-colony stimulating factor
was 2.8- to 7.8-fold higher than in HSC from the BM of untreated mice.
These findings suggest that HSC from frozen cord blood and
cytokine-mobilized BM may be superior targets for amphotropic
retrovirus transduction compared with HSC from untreated adult BM.
Blood, Vol. 91 No. 9 (May 1), 1998:
pp. 3247-3254
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K.-L. Ang, L. Takura Shenje, L. Srinivasan, and M. Galinanes
Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope.
Ann. Thorac. Surg.,
October 1, 2006;
82(4):
1549 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Lucas, N. E. Seidel, C. D. Porada, J. G. Quigley, S. M. Anderson, H. L. Malech, J. L. Abkowitz, E. D. Zanjani, and D. M. Bodine
Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes
Blood,
July 1, 2005;
106(1):
51 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Amit, M. E. Winkler, S. Menke, E. Bruning, K. Buscher, J. Denner, A. Haverich, J. Itskovitz-Eldor, and U. Martin
No Evidence for Infection of Human Embryonic Stem Cells by Feeder Cell-Derived Murine Leukemia Viruses
Stem Cells,
June 1, 2005;
23(6):
761 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Brenner, N. L. Whiting-Theobald, G. F. Linton, K. L. Holmes, M. Anderson-Cohen, P. F. Kelly, E. F. Vanin, A. M. Pilon, D. M. Bodine, M. E. Horwitz, et al.
Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/{beta}2-microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells
Blood,
October 15, 2003;
102(8):
2789 - 2797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hematti, S. E. Sellers, B. A. Agricola, M. E. Metzger, R. E. Donahue, and C. E. Dunbar
Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates
Blood,
March 15, 2003;
101(6):
2199 - 2205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Tsai, H. L. Malech, M. R. Kirby, A. P. Hsu, N. E. Seidel, C. D. Porada, E. D. Zanjani, D. M. Bodine, and J. M. Puck
Retroviral transduction of IL2RG into CD34+ cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras
Blood,
June 17, 2002;
100(1):
72 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Orlic, J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, F. Quaini, B. Nadal-Ginard, D. M. Bodine, A. Leri, and P. Anversa
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
PNAS,
August 10, 2001;
(2001)
181177898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Beltrami, K. Urbanek, J. Kajstura, S.-M. Yan, N. Finato, R. Bussani, B. Nadal-Ginard, F. Silvestri, A. Leri, C. A. Beltrami, et al.
Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction
N. Engl. J. Med.,
June 7, 2001;
344(23):
1750 - 1757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Kelly, J. Vandergriff, A. Nathwani, A. W. Nienhuis, and E. F. Vanin
Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein
Blood,
August 15, 2000;
96(4):
1206 - 1214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Deisseroth
Clinical Trials Involving Multidrug Resistance Transcription Units in Retroviral Vectors
Clin. Cancer Res.,
July 1, 1999;
5(7):
1607 - 1609.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. MacNeill, H. Hanenberg, K. E. Pollok, J. C. M. van der Loo, M. F. A. Bierhuizen, G. Wagemaker, and D. A. Williams
Simultaneous Infection with Retroviruses Pseudotyped with Different Envelope Proteins Bypasses Viral Receptor Interference Associated with Colocalization of gp70 and Target Cells on Fibronectin CH-296
J. Virol.,
May 1, 1999;
73(5):
3960 - 3967.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Whitwam, M. E. Haskins, P. S. Henthorn, J. N. Kraszewski, S. E. Kleiman, N. E. Seidel, D. M. Bodine, and J. M. Puck
Retroviral Marking of Canine Bone Marrow: Long-Term, High-Level Expression of Human Interleukin-2 Receptor Common Gamma Chain in Canine Lymphocytes
Blood,
September 1, 1998;
92(5):
1565 - 1575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Orlic, J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk, F. Quaini, B. Nadal-Ginard, D. M. Bodine, A. Leri, and P. Anversa
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
PNAS,
August 28, 2001;
98(18):
10344 - 10349.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |